Wegovy and Zepbound prior authorization: a criteria checklist
The short answer
Published criteria for Wegovy prior authorization and Zepbound ask for a documented baseline BMI (30, or 27 with a weight-related condition, at Cigna, UnitedHealthcare and FEP Blue; 35 at Aetna; 40 at Highmark). They also ask for proof of a weight program or lifestyle changes lasting 3 to 6 months, and at some insurers a trial of other medicines first.
Key takeaways
- First ask your plan whether it covers weight-management medicines. A prior authorization only works if it does.
- Have your baseline BMI ready with the date it was measured. It's your BMI before treatment.
- Gather dated proof of a weight program or lifestyle changes. Policies count the months.
- List every medicine you've tried, with dates and what happened, because some plans require step therapy.
- Book a weigh-in before your approval ends. Renewals generally depend on documented weight loss from baseline.
A prior authorization is a file your prescriber sends to your plan to show that you meet its written criteria. It’s the plan’s approval before it pays. Plans publish those criteria, and they repeat. We built this checklist from the criteria in published insurer policies. Each item names the insurers that ask for it, so you can see it isn’t guesswork.
Use it to prepare, then get your own plan’s criteria in writing, because yours may differ. It’s part of our insurance guide.
Before the checklist: confirm there is a benefit
A prior authorization only works on a plan that covers the drug. UnitedHealthcare’s program applies only where the employer elected weight-loss coverage. Highmark’s criteria apply only “when a benefit.” Kaiser Permanente Northwest covers Wegovy and Zepbound for weight loss only for members whose plan includes that coverage.
Ask your plan: “Does my plan cover medicines for weight management, and is a prior authorization required?” If the answer to the first part is no, skip to the last section.
The checklist
1. Baseline BMI, with the date it was measured
Every clinical policy in our records starts here.
- BMI of 30 or more, or 27 or more with a weight-related condition: Cigna, UnitedHealthcare, FEP Blue and Kaiser Permanente Northwest.
- Baseline BMI of 35 or more: Aetna policy 6450-C, with documentation required.
- Baseline BMI of 40 or more plus specified obesity-related conditions: Highmark’s Enhanced policy J-1388.
“Baseline” means before treatment. If you’ve already lost weight on the medicine, the file needs your starting figure. Kaiser Permanente Northwest also wants weight and BMI documented in about the last 30 days.
2. Weight-related conditions, if you rely on the lower threshold
If your BMI is between 27 and 30, the condition is what qualifies you, so it has to be in your chart. UnitedHealthcare’s examples are dyslipidemia, hypertension, type 2 diabetes and sleep apnea. FEP Blue names established cardiovascular disease or a weight-related condition. Highmark’s list is narrower: prediabetes with high triglycerides and low HDL, or specified obesity-related organ conditions.
3. Proof of a weight program or lifestyle changes
- Aetna: at least 6 months in a comprehensive weight management program, with continuing follow-up, before the drug.
- Cigna: at least 3 months of behavioral modification and dietary restriction.
- Highmark: at least 6 months of healthy dietary changes and increased physical activity.
- FEP Blue: taking part in a comprehensive weight management program. The policy gives “Teladoc or another weight loss program” as an example.
- Kaiser Permanente Northwest: actively making lifestyle changes, or an active behavioral health referral.
- UnitedHealthcare: used alongside lifestyle modification.
What counts as proof is for your plan to say. But dated visit notes, program enrollment records and dietitian notes are the kind of thing a prescriber’s office attaches. Start dates matter, because the policies count months.
4. Medicines already tried (step therapy)
Step therapy means the plan wants other medicines tried first. Not every insurer asks, but where one does, the plan will look for the record.
- Kaiser Permanente Northwest: a failed 3-month trial of at least two of phentermine, diethylpropion, topiramate, phentermine/topiramate and naltrexone/bupropion before Wegovy. For Zepbound, add a failed trial of semaglutide lasting at least 6 months.
- FEP Blue, Zepbound only: inadequate response, intolerance or contraindication (a medical reason you can’t take it) to at least two oral weight-management medicines, plus a trial of the preferred product unless there’s a valid medical exception.
- Highmark: for Wegovy, Saxenda or Foundayo, a documented intolerance or contraindication to plan-preferred Zepbound.
- Cigna, brand Saxenda on employer plans: generic liraglutide tried first.
For each medicine, list the name, the dates and what happened. If you can’t take one, the reason needs to be documented. Whether any of these medicines is right for you is your prescriber’s decision, not the plan’s.
5. The use the request is for
Plans judge the request against the use it names. Aetna, Cigna and UnitedHealthcare have separate criteria for Wegovy for cardiovascular risk reduction and for Zepbound for moderate to severe obstructive sleep apnea. Aetna and Cigna both ask for a sleep study showing at least 15 events per hour for the sleep apnea route. If one of these applies, your prescriber may file under it.
6. What the request must not include
FEP Blue doesn’t allow use together with another GLP-1 drug or another prior-approval weight-loss drug. Highmark’s criteria require no type 2 diabetes diagnosis and no use with another GLP-1 drug. If you’re changing medicines, the request should make clear the earlier one has stopped.
7. The right form
A request for a form your plan doesn’t list fails before anyone reads the criteria. Aetna’s policy applies to Zepbound pens and not to vials or KwikPens. UnitedHealthcare says Wegovy tablets are typically excluded. Check the form with your plan first.
8. Extra forms at TRICARE
TRICARE requires a prescription from a network provider and a prior authorization form, and for Saxenda a medical necessity form as well.
After approval: the renewal clock
A first approval isn’t open-ended. It runs 8 months at Aetna and Cigna for Wegovy and Zepbound, 6 months at FEP Blue, and 5 months for Wegovy or 6 months for Zepbound at UnitedHealthcare. Renewals are generally for 12 months and depend on documented weight loss from baseline. Aetna also asks for at least 3 months at a stable maintenance dose (the dose you stay on). The exact thresholds are on each insurer’s page: Aetna, Cigna, UnitedHealthcare, FEP Blue, Highmark, Kaiser Permanente and TRICARE.
Book a weigh-in before the approval ends. Dose timing is a matter for your prescriber and the label, and our titration schedule tool shows what each label says about stepping up the dose.
If it is denied, or there is no benefit
Ask for the denial reason and the criteria in writing, then read how to appeal a denial. The appeal letter generator drafts a prior authorization, appeal or formulary exception letter from your details.
If your plan has no weight-loss benefit, the paperwork above won’t change that. The without-insurance guide covers cash prices, which start at $149 a month for Wegovy and $299 for Zepbound.
Frequently asked questions
What are the prior authorization criteria for Wegovy?
They vary by insurer. In the policies we hold, Cigna, UnitedHealthcare and FEP Blue ask for a BMI of 30 or more, or 27 or more with a weight-related condition. Aetna's policy 6450-C asks for a baseline BMI of 35 and 6 months in a weight management program. Kaiser Permanente Northwest asks for a 3-month trial of at least two older medicines first.
What are the prior authorization criteria for Zepbound?
The BMI rules usually match Wegovy's at the same insurer, but Zepbound often has extra steps. FEP Blue asks for at least two oral weight-management medicines and its preferred product first. Kaiser Permanente Northwest asks for at least 6 months of semaglutide first. Highmark's Enhanced policy prefers Zepbound but requires a baseline BMI of 40 plus specified conditions.
Who submits the prior authorization, me or my doctor?
Your prescriber's office submits it, because the plan wants clinical information from the prescriber. You can speed it up by handing over what the criteria ask for: your baseline weight and date, records of a weight program, and the names and dates of medicines you've tried. Ask the office to tell you when it's been sent.
How long does a Wegovy or Zepbound prior authorization last?
The first approval is short. In our records it's 8 months at Aetna and Cigna, 6 months at FEP Blue, and 5 months for Wegovy or 6 months for Zepbound at UnitedHealthcare. Renewals generally run 12 months and require documented weight loss from baseline.
What happens if my prior authorization is denied?
Ask the plan for the reason and the criteria in writing. If a document was missing, your prescriber can resubmit with it. If the plan says a criterion wasn't met and you believe it was, you can appeal. If your plan excludes the drug, the issue is the benefit, not the paperwork. Our appeal guide covers each case.
Sources (12)
- 1.Aetna: Weight Loss (BMI 35) GIP-GLP-1, GLP-1 Agonists PA with Limit 6450-C P08-2025 v8
“Authorization may be granted when the requested drug will be used with a reduced-calorie diet AND increased physical activity to reduce excess body weight or maintain weight reduction long term when ALL of the following criteria are met: ... The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy.”
- 2.Cigna Healthcare: Weight Loss, Glucagon-Like Peptide-1 Agonists, Wegovy Injection (Coverage Policy Number IP0814, dated 2026-09-01)
“Prior Authorization is required for benefit coverage of Wegovy injection (Wegovy and Wegovy HD). ... Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND”
- 3.Cigna Healthcare: Weight Loss, Glucagon-Like Peptide-1 Agonists, Zepbound (Coverage Policy Number IP0816, dated 2026-09-01)
“Prior Authorization is required for benefit coverage of Zepbound. ... Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND”
- 4.UnitedHealthcare: Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage (Program Number 2026 P 1114-23, dated 2026-10-01)
“This is an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification. ... Foundayo, Xenical or Zepbound: Authorization will be issued for 6 months.”
- 5.Blue Cross Blue Shield Federal Employee Program: 5.99.030 Saxenda Wegovy
“Saxenda and Wegovy may be considered medically necessary if the conditions indicated below are met. ... Patient has participated in a comprehensive weight management program (e.g., Teladoc or another weight loss program)”
- 6.Blue Cross Blue Shield Federal Employee Program: 5.99.031 Zepbound
“Zepbound may be considered medically necessary if the conditions indicated below are met. ... the patient has a valid medical exception (e.g., inadequate treatment response, intolerance, contraindication)”
- 7.Kaiser Permanente Northwest Region Criteria for Drug Coverage: semaglutide injectable (Wegovy, Wegovy HD)
“Wegovy injectable is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.”
- 8.Kaiser Permanente Northwest Region Criteria for Coverage: tirzepatide (Zepbound)
“Zepbound is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price. ... Patient has then failed a minimum 6-month trial of semaglutide (Ozempic/Wegovy)”
- 9.Highmark Pharmacy Policy Bulletin: J-1388 Anti-Obesity (Enhanced), Commercial and Healthcare Reform (Version J-1388-028, dated 2026-07-01)
“When a benefit, initiation of Saxenda (liraglutide), Foundayo, Wegovy, or Zepbound may be approved when all of the following criteria are met (1. through 8.): ... contraindication (specifically, documented allergic reaction, hypersensitivity) to plan-preferred Zepbound.”
- 10.TRICARE: Does TRICARE cover Wegovy, Ozempic, and Mounjaro?
“TRICARE covers Wegovy, Saxenda, and Zepbound for weight management if you have coverage under one of these plans: ... Have your provider complete a prior authorization form and medical necessity (Saxenda).”
- 11.
- 12.
Related pages
- What insurance covers Wegovy, Zepbound and other GLP-1 medicines?
- How to appeal a Wegovy or Zepbound insurance denial
- Does Aetna cover Zepbound, Wegovy and other GLP-1s?
- Does Cigna cover Wegovy, Zepbound, Ozempic and Mounjaro?
- Does United Healthcare cover Zepbound and Wegovy?
- Does Blue Cross Blue Shield FEP cover Wegovy, Zepbound and Saxenda?
